Coronary artery disease in 116 kindred with familial type II hyperlipoproteinemia.
about
Correlating corneal arcus with atherosclerosis in familial hypercholesterolemiaCost effectiveness analysis of different approaches of screening for familial hypercholesterolaemiaMortality over two centuries in large pedigree with familial hypercholesterolaemia: family tree mortality studyReductions in all-cause, cancer, and coronary mortality in statin-treated patients with heterozygous familial hypercholesterolaemia: a prospective registry studyThe periodic health examination. Canadian Task Force on the Periodic Health ExaminationRisk of fatal coronary heart disease in familial hypercholesterolaemia. Scientific Steering Committee on behalf of the Simon Broome Register GroupFamilial hypercholesterolemia: Review of diagnosis, screening, and treatmentAn online questionnaire survey of UK general practitioners’ knowledge and management of familial hypercholesterolaemiaTreatment Gaps in Adults With Heterozygous Familial Hypercholesterolemia in the United States: Data From the CASCADE-FH RegistryEnhanced status of inflammation and endothelial activation in subjects with familial hypercholesterolaemia and their related unaffected family members: a case control studyCommon genetic variants do not associate with CAD in familial hypercholesterolemia.Efficacy and safety of proprotein convertase subtilisin/kexin type 9 monoclonal antibody in adults with familial hypercholesterolemiaFamilial hypercholesterolemia: A reviewEfficacy and safety of alirocumab in patients with heterozygous familial hypercholesterolemia not adequately controlled with current lipid-lowering therapy: design and rationale of the ODYSSEY FH studies.Plasma lipid concentrations: the concept of "normality" and its implications for detection of high cardiovascular risk.ABC1: connecting yellow tonsils, neuropathy, and very low HDL.The iron hypothesis:does iron play a role in atherosclerosis?Diet and atherosclerosis: past, present and futureTreatment of anemia in heart failure: potential risks and benefits of intravenous iron therapy in cardiovascular disease.Using body mass index data in the electronic health record to calculate cardiovascular riskDrug therapy of hypercholesterolaemia in children and adolescents.Improved survival of patients with homozygous familial hypercholesterolaemia treated with plasma exchange.Heterozygous familial hypercholesterolemia: an underrecognized cause of early cardiovascular disease.Hypocholesterolemic effects of mevinolin in patients with heterozygous familial hypercholesterolemia.Familial homozygous hypercholesterolemia: clinical and cardiovascular features in 18 patients.Contrasting patterns of coronary atherosclerosis in normocholesterolaemic smokers and patients with familial hypercholesterolaemia.Pediatric lipid management: an earlier approach.Genome-wide association studies in atherosclerosisLipoprotein measurements--a necessity for precise assessment of risk in children from high-risk familiesScreening for familial hyper-beta-lipoproteinaemia in children in hospital.The lipoproteins: predictors, protectors, and pathogens.Cholesterol screening and life assurance.Genetic diagnosis of familial hypercholesterolaemia by targeted next-generation sequencing.Established and emerging coronary risk factors in patients with heterozygous familial hypercholesterolaemia.Plasma lipoprotein levels and the prevalence of hyperlipoproteinemia in a Canadian working population.Plasma lipids and lipoprotein patterns in angiographically graded atherosclerosis of the legs and in coronary heart disease.Cascade testing in familial hypercholesterolaemia: how should family members be contacted?Familial hypercholesterolaemia in children and adolescents: gaining decades of life by optimizing detection and treatment.Changing the conversation regarding pediatric cholesterol screening: the rare disease paradigm.Cost effectiveness of cascade testing for familial hypercholesterolaemia, based on data from familial hypercholesterolaemia services in the UK.
P2860
Q21093276-B3D9521F-9511-486A-8EF6-5A4F8B15D816Q24528552-958AF14C-4EDC-4127-B615-0339A27ADCD7Q24630340-00E34125-FE78-47FF-AC8F-675912E6C791Q24645376-3BD038CC-87A9-4EA8-AB03-31C1C899DAEDQ24669804-BED3C68C-56D9-4604-89D5-9B0DFA6BE996Q24675141-A69212E2-4E65-472A-B6A8-7CF733E9314CQ26770143-A56C5907-6066-44FF-BC73-44DD210DA3E7Q28591611-C737BC85-0238-48B2-9650-94930FDF983AQ31063192-A1B7EB36-6BB2-43D6-A6AB-5831E83247DEQ33601191-D32AA446-75EB-456A-957A-36627E337753Q33620844-37CE89A2-760F-4B4C-9C79-3AB01F8159B4Q33728343-E81D023E-D9EA-4119-AF23-694E2DE76735Q33803782-AF10908A-AB76-4096-9289-CA214DC22218Q33818871-E7551AF1-D7B3-4A92-AE83-AA3F0E990A70Q33838223-442FD065-3F93-4C2C-86DA-0705C801142FQ33870204-3FE75CF6-DE4E-4B58-B7C3-7D2B538135CEQ34014713-3C5805B3-FD39-48D4-87ED-51C37C0E5522Q34052260-723672EC-1180-4247-9F66-B48F1D3FAAA0Q34064046-89CCB4AE-7839-467C-90BD-CF3988B18BE0Q34198287-C5F10D46-8593-497C-9ABC-AC662C118F27Q34268963-0508D4B6-7E1D-4943-B917-727149F9AB43Q34492190-BC9D74E7-574A-4295-9D1F-8EEC819A9C5DQ34499298-49BC29E3-A8B4-49A7-AF1C-883CE4BB3D37Q34621428-B25E4952-1E45-492D-98D4-23D46FA6FD6CQ34677724-8EC5DF6A-8860-4E7F-A4D0-F55253CEE224Q34785390-6DEF9AAD-13FE-4057-B09D-6586139640E5Q34810659-40E48DB8-04EE-4335-965B-882ED54923E8Q34902005-5E5B746E-2672-4EA0-8DC0-8225080EAFEBQ34988473-F6127346-3DCE-4F98-9BCA-0FD414B7EE71Q34989219-144401FF-E40F-4E20-A75B-0408DA3DD502Q34995408-5EEC62A3-6DB5-445F-BF83-C604BFBE98EEQ35178683-044F4C84-E3D2-4DCA-AD46-4D38D7C12384Q35204454-3147C67C-C8CF-4967-BC1A-1374A059DA5DQ35583268-665EF4AD-B0F1-4BEC-B0A8-639DEAA73D0AQ35644647-0A37C4C1-853C-4890-8404-5962028B315EQ35815346-5B7FADF4-908A-49F1-8EE3-27114DF6A23BQ36013242-F69016E4-C7B0-46DB-A623-C6E718E168CAQ36076131-88A0A69C-86B5-426A-A22D-DDEE22490714Q36136088-230070FD-DB80-4B83-AAFA-25F97F0D2193Q36339537-125A1509-7900-4153-8A5F-1A56EE8CEC9D
P2860
Coronary artery disease in 116 kindred with familial type II hyperlipoproteinemia.
description
1974 nî lūn-bûn
@nan
1974年の論文
@ja
1974年学术文章
@wuu
1974年学术文章
@zh
1974年学术文章
@zh-cn
1974年学术文章
@zh-hans
1974年学术文章
@zh-my
1974年学术文章
@zh-sg
1974年學術文章
@yue
1974年學術文章
@zh-hant
name
Coronary artery disease in 116 kindred with familial type II hyperlipoproteinemia.
@en
Coronary artery disease in 116 kindred with familial type II hyperlipoproteinemia.
@nl
type
label
Coronary artery disease in 116 kindred with familial type II hyperlipoproteinemia.
@en
Coronary artery disease in 116 kindred with familial type II hyperlipoproteinemia.
@nl
prefLabel
Coronary artery disease in 116 kindred with familial type II hyperlipoproteinemia.
@en
Coronary artery disease in 116 kindred with familial type II hyperlipoproteinemia.
@nl
P2093
P356
P1433
P1476
Coronary artery disease in 116 kindred with familial type II hyperlipoproteinemia.
@en
P2093
P304
P356
10.1161/01.CIR.49.3.476
P407
P577
1974-03-01T00:00:00Z